Published in Surg Today on November 30, 2011
Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am (2014) 0.95
Factors affecting survival after resection of intrahepatic cholangiocarcinoma. Surg Today (2014) 0.85
The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol (2015) 0.80
Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma. World J Gastrointest Pathophysiol (2014) 0.80
DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study. Surg Today (2013) 0.79
Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors. Dig Dis Sci (2014) 0.79
BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer. Cancer Sci (2015) 0.78
Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford) (2016) 0.76
Benefit of pyloroplasty to prevent gastric stasis in intrahepatic cholangiocarcinoma patients undergoing extensive left-sided lymph node dissection. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75
Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol (2006) 1.65
Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36
Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (2000) 1.25
Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2003) 1.24
Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.20
Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2005) 1.18
Intrahepatic cholangiocarcinoma. World J Surg (1997) 1.11
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma--a study of 51 cases from a low-endemicity area. Acta Oncol (1998) 1.09
Surgical treatment of cholangiocarcinoma. Hepatogastroenterology (1997) 1.09
Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg (1998) 1.08
Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.06
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol (2010) 1.04
Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03
Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg (2002) 0.98
Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2001) 0.97
Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery (2009) 0.97
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg (2008) 0.94
Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells (2005) 3.66
Modified C-V flap in nipple reconstruction. J Plast Reconstr Aesthet Surg (2008) 1.83
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.81
Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res (2003) 1.79
Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem (2004) 1.78
Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas (2004) 1.67
A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg (2014) 1.65
Strategies for improving the outcomes of small-for-size grafts in adult-to-adult living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2008) 1.64
Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol (2002) 1.58
Reconstruction of the middle hepatic vein tributaries using the recipient's recanalized umbilical vein in right-lobe living-donor liver transplantation. Surgery (2006) 1.58
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res (2004) 1.58
PIK3CA mutation and amplification in human lung cancer. Pathol Int (2007) 1.55
Oligomers of Tha4 organize at the thylakoid Tat translocase during protein transport. J Biol Chem (2005) 1.51
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Transplantation (2009) 1.42
A new technique to acquire additional liver volume for left lobe graft in living donor liver transplantation. Hepatogastroenterology (2008) 1.42
Endoscopic submucosal dissection of large colorectal tumors by using a novel spring-action S-O clip for traction (with video). Gastrointest Endosc (2009) 1.38
Is an elderly recipient a risk for living donor adult liver transplantation? Hepatogastroenterology (2008) 1.38
Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg (2007) 1.37
Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas (2008) 1.33
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology (2007) 1.33
Cancer stem cells in human gastrointestinal cancers. Hum Cell (2006) 1.30
Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology (2003) 1.29
Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways. Exp Cell Res (2007) 1.29
JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol Cell Biol (2003) 1.28
Functional interaction of chloroplast SRP/FtsY with the ALB3 translocase in thylakoids: substrate not required. J Cell Biol (2003) 1.23
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res (2003) 1.21
Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients. Ann Surg Oncol (2006) 1.20
MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene (2003) 1.19
Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol (2012) 1.18
Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett (2005) 1.18
Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst (2006) 1.16
Rapid-growing solitary necrotic nodule of the liver. J Med Invest (2006) 1.15
Quality control of photosystem II. Cleavage of reaction center D1 protein in spinach thylakoids by FtsH protease under moderate heat stress. J Biol Chem (2006) 1.14
Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery (2002) 1.14
The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol (2011) 1.13
Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection. Surg Endosc (2012) 1.12
Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer (2003) 1.12
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation (2009) 1.10
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol (2009) 1.10
Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation (2007) 1.10
Establishment of regional alliance clinical pathways for gastrointestinal cancer in Tokushima. Fukuoka Igaku Zasshi (2011) 1.09
Risk model for right hemicolectomy based on 19,070 Japanese patients in the National Clinical Database. J Gastroenterol (2013) 1.09
A practical synthesis of (S)-2-cyclohexyl-2-phenylglycolic acid via organocatalytic asymmetric construction of a tetrasubstituted carbon center. Org Lett (2005) 1.08
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res (2005) 1.07
Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg (2014) 1.07
Double-balloon endoscopy for treatment of long-term abdominal discomfort due to small bowel penetration by an eel bone. Med Sci Monit (2008) 1.07
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res (2005) 1.06
Accurate preoperative estimation of liver-graft volumetry using three-dimensional computed tomography. Transplantation (2003) 1.05
Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas (2006) 1.05
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol (2010) 1.04
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy. Cancer Chemother Pharmacol (2013) 1.03
Biliary strictures in living donor liver transplantation: incidence, management, and technical evolution. Liver Transpl (2006) 1.03
MAGI-1 is a component of the glomerular slit diaphragm that is tightly associated with nephrin. Lab Invest (2005) 1.03
Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology (2003) 1.03
Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation. Lung Cancer (2007) 1.03
Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03
Sonic hedgehog relates to colorectal carcinogenesis. J Gastroenterol (2009) 1.02
Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci U S A (2008) 1.02
Significance of skp2 expression in primary breast cancer. Clin Cancer Res (2006) 1.02
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery (2002) 1.01
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev (2004) 1.01
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01
The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection. Surg Today (2011) 1.01
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology (2002) 1.01
Evaluation of reconstruction after proximal gastrectomy: prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology (2006) 1.00
Somatic mutations of epidermal growth factor receptor in colorectal carcinoma. Clin Cancer Res (2005) 1.00
Synthesis, characterization, and transistor and solar cell applications of a naphthobisthiadiazole-based semiconducting polymer. J Am Chem Soc (2012) 1.00
Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00
The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep (2003) 1.00
Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study). Jpn J Clin Oncol (2009) 0.99
Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl (2003) 0.99
Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. J Med Invest (2004) 0.99
Significance of sonic hedgehog signaling after massive hepatectomy in a rat. Surg Today (2012) 0.98
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol (2005) 0.98
Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today (2010) 0.98